THANK YOU FOR SUBSCRIBING
The premeditated amalgamation will strengthen KabaFusion's position as one of the leading clinical-led home infusion company in the United States
Fremont, CA: Kabafusion, a leading provider of patient-focused infusion therapy, announced that it had acquired the home infusion assets of Lincare, a subsidiary of Linde plc. The premeditated amalgamation will strengthen KabaFusion's position as one of the leading clinical-led home infusion company in the United States. It will also enhance the company's ability to provide superior patient care significantly across the broad range of home infusion therapies countrywide.
Founded by Dr. Sohail Masood, KabaFusion has been a pioneering leader in patient-focused home infusion services with deep clinical expertise in intravenous immunoglobulin (IVIG) therapies. KabaFusion, with the help of the additional infusion operations by Lincare, can expand its footprints to 28 home infusion specialty pharmacies. The key strategic markets include New York, Florida, Alabama, Kentucky, Arkansas, Indiana, New Jersey, Michigan, North Carolina, Virginia, and Wyoming, in addition to the KabaFusion's existing pharmacies in California, Pennsylvania, Florida, Illinois, New Jersey, Massachusetts, and Texas. The company has the license to serve patients in 44 states with an all-inclusive offering of acute, chronic, and enteral therapies.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
"We are excited to expand our national network with the infusion pharmacies from Lincare, who shares our values and our deep commitment to patient care," said Dr. Sohail Masood, founder and Chief Executive Officer of KabaFusion. "We look forward to combining the best of both our teams, as together we will be even better positioned to continue delivering high-quality home infusion services to achieve the best possible outcome for each of our patients."
This acquisition is first of its kind for KabaFusion since it partnered with Pritzker Private Capital in January 2019. Ceron Rhee of Pritzker Private Capital said, "We are pleased to welcome Lincare's infusion team to the KabaFusion and Pritzker Private Capital families. The combination of KabaFusion's patient-focused leadership in IVIG with Lincare's long-standing presence in complementary markets uniquely positions the company for continued exceptional growth under Dr. Masood's leadership."
The clinician-led management team of KabaFusion will continue to lead the joint company in working with healthcare providers, patients, hospitals, and payors across the United States. It promises to deliver the highest quality of home infusion services with unparalleled clinical excellence.
See Also :- Top Healthcare Solution Companies
More in News